Skip to main content
Premium Trial:

Request an Annual Quote

MDS Pharma, Caprion, Gentris, MGH, Partner on Biomarker Discovery Services

NEW YORK, June 17 (GenomeWeb News) - Caprion Pharmaceuticals, Gentris, Massachusetts General Hospital Department of Radiology, and MDS Pharma Services have founded the Biomarker Alliance, which will offer the members' biomarker discovery services, the organization said yesterday.

 

Customers will have access to Caprion's protein biomarker services, Gentris' clinical pharmacogenomic services, MGH's imaging biomarker technology, and MDS Pharma Services' biomarker discovery.

 

In a statment, the alliance members said that they have created "the only organization providing single-point access to proteomics, pharmacogenomics, imaging, assay development and clinical testing" together in a single service

 

MDS Pharma Services, which spearheaded the formation of the partnership, will also manage access to the group's services.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.